Inpatient Opioid Safety Act of 2021
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Inpatient Opioid Safety Act of 2021
This bill requires hospitals, as a condition of Medicare and Medicaid participation, to use specified technology to monitor patients for opioid-induced respiratory depression for 12 hours after the administration of an opioid or until the patient is discharged, whichever is earlier, unless a health care practitioner determines before administering an opioid that such monitoring should not be used and records this determination in the patient's record.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5932: Inpatient Opioid Safety Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5932/
"H.R. 5932: Inpatient Opioid Safety Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5932/.
H.R. 5932, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5932/.
[H.R. 5932: Inpatient Opioid Safety Act of 2021](https://openamerica.io/bill/117-HR-5932/)